Answers are grounded in this paper and cite their sources.
Immunotoxins are conjugates of cell-reactive antibodies and toxins or their subunits. In this report, the chemistry, biology, pharmacokinetics, and anti-tumor effects of first generation immunotoxins; the preparation of improved second generation immunotoxins that display greater anti-tumor efficacy; and the role of genetic engineering in creating third-generation immunotoxins are discussed.
No takes yet. Share an insight, caveat, or question.
Vitetta et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: